2009 Nobel Prize in Physiology or Medicine: Telomeres and telomerase

Oncogene

Volumn 29, Issue 11, 2010, Pages 1561-1565

  Varela, E ^a   Blasco, M A ^a  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

AGING; AWARDS AND PRIZES; CELL DIVISION; EDITORIAL; ENZYME ACTIVITY; HUMAN; MEDICAL RESEARCH; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; STEM CELL; TELOMERE;

AGING; BIOMEDICAL RESEARCH; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; MEDICINE; NEOPLASMS; NOBEL PRIZE; PHYSIOLOGY; STEM CELLS; TELOMERASE; TELOMERE;

EID: 77949633751     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.15     Document Type: Editorial

References (83)

1. Artandi SE, Alson S, Tietze MK, Sharpless NE, Ye S, Greenberg RA, et al. (2002). Constitutive telomerase expression promotes mammary carcinomas in aging mice. Proc Natl Acad Sci USA 99: 8191-8196.
2. Azzalin CM, Lingner J. (2008). Telomeres: the silence is broken. Cell Cycle 7: 1161-1165.
3. Azzalin CM, Reichenbach P, Khoriauli L, Giulotta E, Lingner J. (2007). Telomeric repeat containing RNA and RNA surveillance factors at mammalian chromosome ends. Science 318: 798-801.
4. Bateman AJ. (1975). Letter: simplification of palindromic telomere theory. Nature 253: 379-380.
5. Baur JA, Zou Y, Shay JW, Wright WE. (2001). Telomere position effect in human cells. Science 292: 2075-2077.
6. Bell DR, Van Zant G. 2004. Stem cells, aging, and cancer: inevitabilities and outcomes. Oncogene 23: 7290-7296.
7. Blackburn EH. (2000). Telomere states and cell fates. Nature 408: 53-56.
8. Blackburn EH. (2001). Switching and signaling at the telomere. Cell 106: 661-673.
9. Blackburn EH. (2005). Cell biology: shaggy mouse tales. Nature 486: 922-923.
10. Blackburn EH, Gall JG. (1978). A tandemly repeated sequence at the termini of the extrachromosomal ribosomal RNA genes in Tetrahymena. J Mol Biol 120: 33-53.
11. Blackburn EH, Greider CW, Szostak JW. (2006). Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging. Nat Med 12: 1133-1138.
12. Blasco MA. (2005). Telomeres and human disease: ageing, cancer and beyond. Nat Rev Genet 6: 611-622.
13. Blasco MA. (2007). The epigenetic regulation of mammalian telomeres. Nat Rev Genet 8: 299-309.
14. Blasco MA, Lee HW, Hande MP, Samper E, Lansdorp PM, DePinho RA, et al. (1997). Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91: 25-34.
15. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, et al. (1998). Extension of life-span by introduction of telomerase into normal human cells. Science 279: 349-352.
16. Bryan TM, Reddel RR. (1997). Telomere dynamics and telomerase activity in in vitro immortalised human cells. Eur J Cancer 33: 767-773.
17. Canela A, Martin-Caballero J, Flores JM, Blasco MA. (2004). Constitutive expression of Tert in thymocytes leads to increased incidence and dissemination of T-cell lymphoma in Lck-Tert mice. Mol Cell Biol 24: 4275-4293.
18. Cavalier-Smith T. (1974). Palindromic base sequences and replication of eukaryote chromosome ends. Nature 250: 467-470.
19. Chan SR, Blackburn EH. (2004). Telomeres and telomerase. Trans R Soc Land Biol Sci 359: 109-121.
20. Choudhury AR, Ju Z, Djojosubroto MW, Schienke A, Lechel A, Schaetzlein S, et al. (2007). Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation. Nat Genet 39: 99-105.
21. Collins K, Mitchell JR. (2002). Telomerase in the human organism. Oncogene 21: 564-579.
22. Cooper JP, Nimmo ER, Allshire RC, Cech TR. (1997). Regulation of telomere length and function by a Myb-domain protein in fission yeast. Nature 385: 744-747.
23. Counter CM, Hirte HW, Bacchetti S, Harley CB. (1994). Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA 91: 2900-2904.
24. Dancis BM, Holmquist GP. (1979). Telomere replication and fusion in eukaryotes. J Theor Biol 78: 211-224.
25. De Lange T. (2005). Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 19: 2100-2110.
26. Dunn B, Szauter P, Pardue ML, Szostak JW. (1984). Transfer of yeast telomeres to linear plasmids by recombination. Cell 39: 191-201.
27. Espejel S, Klatt P, Menissier-de Murcia J, Martin-Caballero J, Flores JM, Taccioli G, et al. (2004). Impact of telomerase ablation on organismal viability, aging, and tumorigenesis in mice lacking the DNA repair proteins PARP-1, Ku86 or DNA-PKcs. J Cell Biol 167: 627-638.
28. Flores I, Benetti R, Blasco MA. (2006). Telomerase regulation and stem cell behaviour. Curr Opin Cell Biol 18: 254-260.
29. Flores I, Cayuela ML, Blasco MA. (2005). Effects of telomerase and telomere length on epidermal stem cell behavior. Science 309: 1253-1256.
30. Garcia-Cao M, O'Sullivan R, Peters AH, Jenuwein T, Blasco MA. (2004). Epigenetic regulation of telomere length in mammalian cells by the Suv39h1 and Suv39h2 histone methyltransferases. Nat Genet 36: 94-99.
31. Gonzalez-Suarez E, Geserick C, Flores JM, Blasco MA. (2005). Antagonistic effects of telomerase on cancer and aging in K5-mTert transgenic mice. Oncogene 24: 2256-2270.
32. Gonzalez-Suarez E, Samper E, Flores JM, Blasco MA. (2000). Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis. Nat Genet 26: 114-117.
33. Gonzalez-Suarez E, Samper E, Ramirez A, Flores JM, Martin-Caballero J, Jorcano JL, et al. (2001). Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes. EMBO J 20: 2619-2630.
34. Gonzalo S, Jaco I, Fraga MF, Chen T, Li E, Esteller M, et al. (2006). DNA methytransferases control telomere length and telomere recombination in mammalian cells. Nat Cell Biol 8: 416-424.
35. Gottschling DE, Aparicio CM, Billington BL, Zakian VA. (1990). Position effect at S. cerevisiae telomeres: reversible repression of Pol II transcription. Cell 16: 751-762.
36. Greenberg RA, Chin L, Femino A, Lee KH, Gottlieb GJ, Singer RH, et al. (1999). Short dysfunctional telomeres impair tumorigenesis in the INK4a(delta2/3) cancer-prone mouse. Cell 97: 515-525.
37. Greider CW, Blackburn EH. (1985). Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43: 405-413.
38. Greider CW, Blackburn EH. (1987). The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell 51: 887-898.
39. Greider CW, Blackburn EH. (1989). A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature 337: 331-337.
40. Griffith JD, Comeau L, Rosenfield S, Stansel RM, Bianchi A, Moss H, et al. (1999). Mammalian telomeres end in a large duplex loop. Cell 97: 503-514.
41. Hackett JA, Feldser DM, Greider CW. (2001). Telomere dysfunction increases mutationrate and genomic instability. Cell 108: 275-286.
42. Hackett JA, Greider CW. (2002). Balancing instability: dual roles for telomerase and telomere dysfunction in tumorigenesis. Oncogene 21: 619-626.
43. Hande MP, Samper E, Lansdorp P, Blasco MA. (1999). Telomere length dynamics and chromosomal instability in cells derived from telomerase null mice. J Cell Biol 22: 589-601.
44. Hao LY, Armanios M, Strong MA, Karim B, Feldser DM, Huso D, et al. (2005). Short telomeres, even in the presence of telomerase, limit tissue renewal capacity. Cell 16: 1121-1131.
45. Harley CB. (2008). Telomerase and cancer therapeutics. Nat Rev Cancer 8: 167-179.
46. Harley CB, Futcher AB, Greider CW. (1990). Telomeres shorten during ageing of human fibroblasts. Nature 345: 458-460.
47. Hayflick L. (1998). A brief history of the mortality and immortality of cultured cells. Keio J Med 47: 174-182.
48. Hayflick L, Moorhead PS. (1961). The serial cultivation of human diploid cell strains. Exp Cell Res 25: 585-621.
49. Hermann MT, Strong MA, Hao LY, Greider CW. (2001). The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 107: 67-77.
50. Herrera E, Martinez AC, Blasco MA. (2000). Impaired germinal center formation in telomerase-deficient mice. EMBO J 19: 472-481.
51. Herrera E, Samper E, Martin-Caballero J, Flores JM, Lee HW, Blasco MA. (1999). Disease states associated to telomerase deficiency appear earlier in mice with short telomeres. EMBO J 18: 2950-2960.
52. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, et al. (1994). Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015.
53. Kolquist KA, Ellisen LW, Counter CM, Meyerson M, Tan LK, Weinberg RA, et al. (1998). Expression of TERT in early premalignant lesions and a subset of cells in normal tissues. Nat Genet 19: 182-186.
54. Lee HW, Blasco MA, Gottlieb GJ, Greider CW, DePinho RA. (1998). Essential role of mouse telomerase in highly proliferative organs. Nature 392: 569-574.
55. Li S, Crothers J, Hagg CM, Blackburn EH. (2005). Cellular and gene expression responses involved in the rapid growth inhibition of human cancer cells by RNA interference-mediated depletion of telomerase RNA. J Biol Chem 280: 23709-23717.
56. Luke B, Lingner J. (2009). TERRA: telomeric repeat-containing RNA. EMBO J 28: 2503-2510.
57. Lundblad V, Szostak JW. (1989). A mutant with a defect in telomere elongation leads to senescence in yeast. Cell 57: 633-643.
58. Mason PJ, Wilson D, Bessler M. (2005). Dyskeratosis congenita-a disease of dysfunctional telomere maintenance. Curr Mol Med 5: 159-170.
59. McClintock B. (1939). The behavior in successive nuclear divisions of a chromosome broken at meiosis. Proc Natl Acad Sci USA 25: 405-416.
60. McClintock B. (1941). The stability of broken ends of chromosomes in Zea Mays. Genetics 28: 234-282.
61. McKay JD, Hung RJ, Gaborieau V, Boffetta P, Chabrier A, Byrnes G, et al. (2008). Lung cancer susceptibility locus at 5p15.33. Nat Genet 40: 1404-1406.
62. Mitchell JR, Wood E, Collins K. (1999). A telomerase component is defective in the human disease dyskeratosis congenita. Nature 402: 551-555.
63. Morrish TA, Greider CW. (2009). Short telomeres initiate telomere recombination in primary and tumor cells. PLoS Genet 5: e1000357.
64. Muller HJ. (1938). Bar duplication. Collecting Net (Woods Hole) 13: 181-198.
65. Olovnikov AM. (1971). Principle of marginotomy in template synthesis of polynucleotides. Dokl Akad Nauk SSSR 201: 1496-1499.
66. Olovnikov AM. (1973). A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J Theor Biol 41: 181-190.
67. Palladino F, Laroche T, Gilson E, Axelrod A, Philus L, Gasser SM. (1993). SIR3 and SIR4 proteins are required for the positioning and integrity of yeast telomeres. Cell 75: 543-555.
68. Pardue ML, DeBaryshe PG. (2003). Retrotransposons provide an evolutionarily robust non-telomerase mechanism to maintain telomeres. Annu Rev Genet 37: 485-511.
69. Rafnar T, Sulen P, Stacey SN, Geller F, Gudmundsson J, Sigurdsson A, et al. (2009). Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat Genet 41: 221-227.
70. Samper E, Goytisolo FA, Menissier-de Murcia J, Gonzalez-Suarez E, Cigudosa JC, de Murcia G, et al. (2001). Normal telomere length and chromosomal end-capping in poly (ADP-ribose) polymerase deficient mice and primary cells despite increased chromosomal instability. J Cell Biol 154: 49-60.
71. Sarin KY, Cheung P, Gilson D, Lee E, Tennen RL, Wang E, et al. (2005). Conditional telomerase induction causes proliferation of hair follicle stem cells. Nature 436: 1048-1052.
72. Schoeftner S, Blasco MA. (2008). Developmentally regulated transcription of mamalian telomeres by DNA dependent RNA polymerase II. Nat Cell Biol 10: 228-236.
73. Schoeftner S, Blasco MA. (2009a). A higher order of telomere regulation: telomere heterochromatin and telomeric RNAs. EMBO J 28: 2323-2336.
74. Schoeftner S, Blasco MA. (2009b). Chromatin regulation and non-coding RNAs at mammalian telomeres. Semin Cell Dev Biol. (e-pub ahead of print).
75. Shampay J, Szostak JW, Blackburn EH. (1984). DNA sequences of telomeres maintained in yeast. Nature 310: 154-157.
76. Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, Malmer B, et al. (2009). Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 4: 899-904.
77. Siegl-Cachedenier I, Munoz P, Flores JM, Klatt P, Blasco MA. (2007). Deficient mismatch repair improves organismal fitness and survival of mice with dysfunctional telomeres. Genes Dev 21: 2234-2247.
78. Stacey SN, Sulem P, Masson G, Bergthorsson JT, Kumar R, Thorleifsson G, et al. (2009). Common variants on 1p36 and 1q42 are associated with cutaneous basal cell carcinoma but not with melanoma or pigmentation traits. Nat Genet 41: 809-814.
79. Szostak JW, Blackburn EH. (1982). Cloning yeast telomeres on linear plasmid vectors. Cell 29: 245-255.
80. Tomas-Loba A, Flores I, Fernandez-Marcos PJ, Cayuela ML, Maraver A, Tejera A, et al. (2009). Telomerase reverse transcriptase delays aging in cancer resistant mice. Cell 135: 609-622.
81. Vera E, Canela A, Fraga MF, Esteller M, Blasco MA. (2008). Epigenetic regulation of telomeres in human cancer. Oncogene 27: 8817-8833.
82. Watson JD. (1972). Origin of concatemeric T7 DNA. Nat New Biol 239: 197-201.
83. Wong KK, Maser RS, Bachoo RM, Menon J, Carrasco DR, Gu Y, et al. (2003). Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing. Nature 421: 643-648.